Dupilumab in Adults with Moderate-To-Severe Atopic Dermatitis and Prior Use of Systemic Non-Steroidal-Immunosuppressants: Analysis of Four Phase 3 Trials
mediaposted on 2021-06-15, 13:36 authored by Adis journals on behalf of:, Christopher Griffiths, Marjolein de Bruin-Weller, Mette Deleuran, Maria Concetta Fargnoli, Delphine Staumont-Sallé, Chih-ho Hong, Jose Sánchez-Carazo, Peter Foley, Seong Jun Seo, Jérôme Msihid, Zhen Chen, Sonya L. Cyr, Ana B. Rossi
Article full text
The above video and graphical abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.